Tailored Toxicity-Driven Administration of Vismodegib in Patients With Multiple or Locally Advanced Basal Cell Carcinoma: A Pilot Analysis

Tailored Toxicity-Driven Administration of Vismodegib in Patients With Multiple or Locally Advanced Basal Cell Carcinoma: A Pilot Analysis

In this pilot study, we describe our experience with vismodegib in the treatment of basal cell carcinoma (BCC) and evaluate the feasibility of a tailored toxicity-driven administration of vismodegib in patients with multiple or locally advanced BCC. We retrospectively analyzed the clinical charts of...

Full description

Bibliographic Details
Main Authors: Maria Chiara Tronconi, Alessandra Solferino, Laura Giordano, Riccardo Borroni, Luca Mancini, Armando Santoro
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-11-01
Series:Frontiers in Oncology
Subjects:
basal cell carcinoma
vismodegib
tailored treatment
toxicity
schedule
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2020.563404/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2020.563404/full

Similar Items